slides · global inventory
Comparison Frame
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,294
Current window 4,651-4,680
Pages 210
Rows per page 30
Framework
4,651-4,680 of 6,294
47
The slide uses a contrast-based layout to frame the subject as a winner in a difficult therapeutic space.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
54
The slide uses a comparison frame to position ERAS-601 against competitors like Novartis, Revolution Medicines, Jacobio, Genentech, Pfizer, and Merck.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
26
The slide uses a comparison table to contrast Ku-band and Ka-band specifications.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
30
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
55
The slide uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
68
The slide uses a heatmap-style table to compare the company's asset against competitors, with a specific callout box around the UGT1A1 row.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
16
The slide uses a side-by-side comparison framework to contrast a branch purchase with a whole bank acquisition.First Western Financial | Investor Presentation Deck | 50 slides · First Western Financial
Pitch deck Investor relations Loop · Zoom In1 hit
14
The slide uses a line chart to demonstrate historical credit quality performance and a text box to highlight current portfolio resilience metrics.Flushing Financial | Investor Conference Presentation Deck | 38 slides · Flushing Financial
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Uses a visual contrast strategy to define market niche and risk profile.Flushing Financial | Investor Presentation Deck | 35 slides · Flushing Financial Corporation
Pitch deck Investor relations Beat · Solution1 hit
16
The chart shows FFIC consistently outperforming the industry in net charge-offs.Flushing Financial | Investor Presentation Deck | 35 slides · Flushing Financial Corporation
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
The chart highlights FFIC's superior credit performance relative to the industry average.Flushing Financial | Results Presentation Deck | 37 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
16
Uses a comparison frame to illustrate why EV and ESS markets are decoupling.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
15
The slide uses a waterfall plot comparison to contrast clinical outcomes of two different therapeutic modalities.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
32
The slide uses a potency spectrum chart to frame the problem of toxin evolution and a comparison table to highlight the competitive advantages of TATs.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
06
The slide uses a 'before-after' or 'us-vs-them' framing to highlight the company's sustainability leadership.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Humble Origins1 hit
16
The slide uses a comparison table for efficacy and callout boxes for sustainability, supported by a footer of certification logos.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Rising Success1 hit
10
The slide uses a series of horizontal bar charts to demonstrate market leadership in deal counts.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · Market Size1 hit
09
The chart highlights Hugo Boss in a distinct color (gold) compared to the grey bars of competitors.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
71
The slide uses a comparative structure to show the shift in sourcing strategy (nearshoring) to align with regional sales.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Jobs To Be Done1 hit
103
The slide uses a clear side-by-side comparison framework to explain executive compensation structure.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · Visualization1 hit
19
The slide uses a red dashed box to highlight the key efficacy metrics for comparison.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
46
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo, likely to frame the market opportunity for IMX-120.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
10
Includes detailed source citations in the footer.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
06
The slide explicitly notes that these are cross-trial comparisons and not head-to-head studies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
07
The slide uses a table structure to contrast standard of care with the company's target segment. The bottom section uses bar charts to imply relative patient population growth.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
08
The slide explicitly warns about cross-trial comparison limitations in the footer.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
20
The slide explicitly notes that these are cross-trial comparisons, not head-to-head studies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
21
Includes detailed source citations and disclaimer regarding cross-trial comparisons.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
23
The slide uses a two-column layout to contrast clinical results for Multiple Myeloma vs. AL Amyloidosis, supported by market data for existing therapies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
52
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit